• Allergy, Asthma & Immunology Research
• /
• 제10권6호
• /
• pp.614-627
• /
• 2018

Purpose: Asthma is a heterogeneous disease that responds to medications to varying degrees. Cluster analyses have identified several phenotypes and variables related to fixed airway obstruction; however, few longitudinal studies of lung function have been performed on adult asthmatics. We investigated clinical, demographic, and inflammatory factors related to persistent airflow limitation based on lung function trajectories over 1 year. Methods: Serial post-bronchodilator forced expiratory volume (FEV) 1% values were obtained from 1,679 asthmatics who were followed up every 3 months for 1 year. First, a hierarchical cluster analysis was performed using Ward's method to generate a dendrogram for the optimum number of clusters using the complete post-FEV1 sets from 448 subjects. Then, a trajectory cluster analysis of serial post-FEV1 sets was performed using the k-means clustering for the longitudinal data trajectory method. Next, trajectory clustering for the serial post-FEV1 sets of a total of 1,679 asthmatics was performed after imputation of missing post-FEV1 values using regression methods. Results: Trajectories 1 and 2 were associated with normal lung function during the study period, and trajectory 3 was associated with a reversal to normal of the moderately decreased baseline FEV1 within 3 months. Trajectories 4 and 5 were associated with severe asthma with a marked reduction in baseline FEV1. However, the FEV1 associated with trajectory 4 was increased at 3 months, whereas the FEV1 associated with trajectory 5 was persistently disturbed over 1 year. Compared with trajectory 4, trajectory 5 was associated with older asthmatics with less atopy, a lower immunoglobulin E (IgE) level, sputum neutrophilia and higher dosages of oral steroids. In contrast, trajectory 4 was associated with higher sputum and blood eosinophil counts and more frequent exacerbations. Conclusions: Trajectory clustering analysis of FEV1 identified 5 distinct types, representing well-preserved to severely decreased FEV1. Persistent airflow obstruction may be related to non-atopy, a low IgE level, and older age accompanied by neutrophilic inflammation and low baseline FEV1 levels.

• 대한한방부인과학회지
• /
• 제28권1호
• /
• pp.13-28
• /
• 2015

Objectives: To observe the in vitro anti-inflammatory effects of Hyunbulikyung-tang aqueous extracts (HBLKT) and the possible synergic combination effects with a nonsteroidal anti-inflammatory drug, piroxicam. Methods: Anti-inflammatory effects of HBLKT (yield=16.17%) were observed on LPS activated raw 264.7 cells based on $ED_{50}$ to cell viability, NO, $PGE_2$, $TNF-{\alpha}$, $IL-1{\beta}$ and IL-6 productions as compared with piroxicam, in the present study. In addition, the combination effects of HBLKT with piroxicam were observed after treatment of HBLKT 1/4 $ED_{50}$ + piroxicam 1/4 $ED_{50}$, 1/8 $ED_{50}$, 1/16 $ED_{50}$, 1/32 $ED_{50}$ and 1/64 $ED_{50}$ concentrations, respectively. Results: Significant (p<0.01 or p<0.05) increases of cell viabilities and decreases of NO, $PGE_2$, $TNF-{\alpha}$, $IL-1{\beta}$ and IL-6 cytokine releases were detected in HBLKT 1/4 $ED_{50}$ + piroxicam 1/4 $ED_{50}$, 1/8 $ED_{50}$, 1/16 $ED_{50}$ and 1/32 $ED_{50}$ concentration co-treatment as compared with each of single 1/4 $ED_{50}$ concentration of piroxicam and HBLKT treatments, respectively. Although significant (p<0.01 or p<0.05) increases of cell viabilities and decreases of NO, $PGE_2$, $TNF-{\alpha}$, $IL-1{\beta}$ and IL-6 cytokine releases were also demonstrated in piroxicam 1/64 $ED_{50}$ + HBLKT 1/4 $ED_{50}$ co-treatment as compared with LPS control, no significant changes were detected as compared with each of single 1/4 $ED_{50}$ concentration of piroxicam and HBLKT treatments, in this experiment. Conclusions: Hyunbulikyung-tang showed cell protective and anti-inflammatory effects against LPS activated raw 264.7 cells. It, therefore, expected that HBLKT will be showed favorable effects to relieve dysmenorrhea related to over expressed inflammatory cytokines, and it also expected that the clinical dosages of piroxicam can be reduced as 1/8 levels as combination with HBLKT.

• 대한한방부인과학회지
• /
• 제27권1호
• /
• pp.65-80
• /
• 2014

Objectives: The object of this study was to observe the in vitro antibacterial effects of Gagam-seopyoungjeon aqueous extracts (GGSYJ) against Gardnerella vaginalis and the possible synergic combination effects with clindamycin. Methods: Antibacterial activities against Gardnerella vaginalis of GGSYJ were detected using minimal inhibition concentration (MIC), and the effects on the bacterial growth curve were also monitored at MIC and MIC${\times}$2 levels. The combination effects of GGSYJ with clindamycin were observed by checkboard microtiter assay, and the effects of bacterial growth curve treated with GGSYJ MIC+clindamycin MIC, 1/2 MIC and 1/4 MIC, respectively. The effects on the bacterial invasion and intracellular killing of GGSYJ were also observed using human vaginal epithelial (VK2) and murine macrophage (Raw264.7) cells with combination effects with clindamycin after treatment of GGSYJ MIC+clindamycin 1/2 MIC, 1/4 MIC and 1/6 MIC, respectively. Results: The MIC of clindamycin and GGSYJ against Gardnerella vaginalis were detected as $0.012{\pm}0.006$ (0.004~0.016)${\mu}g/ml$ and $1.016{\pm}0.524$ (0.391~1.563) mg/ml, respectively. Clindamycin and GGSYJ were also showed marked dosage-dependent inhibition of bacterial growth, and significant decreases of viable cells were detected in clindamycin MIC+GGSYJ MIC and clindamycin 1/2 MIC+GGSYJ MIC treatment as compared with each of single clindamycin MIC and GGSYJ MIC treatments. And significant decreases of intraepithelial and intra-macrophage viable bacteria numbers were detected in clindamycin 1/2 MIC+GGSYJ 1/2 MIC and clindamycin 1/4 MIC+GGSYJ 1/2 MIC treatment as compared with each of single clindamycin GGSYJ 1/2 MIC treatments, respectively. Conclusions: GGSYJ showed slight antibacterial effects against Gardnerella vaginalis, but they showed dosage-dependent inhibitory effects on the bacterial growth and VK2 epithelial invasions of bacteria with favorable accelerating effects of intracellular killing activities of macrophages. In addition, combination of GGSYJ also increased the inhibitory effects of clindamycin on the epithelial invasions of Gardnerella vaginalis and intracellular killing activities of macrophages against Gardnerella vaginalis as 2-fold higher as compared with clindamycin single treatment, respectively. Therefore, we expected that the clinical dosages of clindamycin can be reduced as 1/2 levels as combination with GGSYJ.

• 대한한방부인과학회지
• /
• 제30권3호
• /
• pp.1-19
• /
• 2017

목 적: 본 연구는 녹용대보탕이 안와정맥총 방혈로 유발시킨 랫트의 아급성 출혈성 빈혈 모델에 대해 항빈혈 및 조혈촉진 효과를 확인하였다. 방 법: 본 실험에서는 안와 정맥총에서 혈액을 채혈하여 아급성 출혈성 빈혈을 유발시켰으며, 녹용대보탕 추출물을 경구투여하고, 체중 및 조혈 관련 장기(대퇴골 골수, 비장 및 간) 중량, 적혈구 관련 혈액학적 지표의 변화, 혈액 도말 표본의 세포학적 변화, 조혈관련 장기의 조직병리학적 변화와 함께 조혈장기 내 혈구형성 줄기세포의 수적 변화를 면역조직화학적으로 관찰하였다. 또한 철분 보충제의 대표적 부작용인 소화 장애, 특히 변비 유발 여부를 확인하기 위해 탄분을 이용해 위장관 운동성을 평가하였으며, 결장내 분변 표면의 점막 두께와 결장점막 내 점액생산세포 및 결장 점막 두께 변화를 조직병리학적으로 평가하였다. 결 과: 본 실험에서 유발된 아급성 출혈성 빈혈 소견이 모든 세 용량의 녹용대보탕 추출물의 용량 의존적으로 현저히 억제되었다. 또한 세 용량의 녹용대보탕 투여군에서는 정상 대조군 및 아급성 출혈성 빈혈 대조군에 비해 위장관 운동성 변화 및 결장 및 결장내 분변의 점액성분의 유의미한 변화는 없었다. 결 론: 이상의 결과에서, 녹용대보탕의 경구투여는 아급성 출혈성 빈혈 유발 랫트에서 단순 철분 보충제의 부작용인 소화관 장애 없이, 조혈관련 장기들에서 혈구형성줄기세포의 증식 촉진을 통해 투여 용량 의존적으로 철 결핍성 빈혈의 증상을 현저히 완화시키는 것으로 관찰되었다. 따라서 녹용대보탕은 새로운 개념의 조혈촉진 빈혈치료제로서의 개발 가치가 충분할 것으로 판단된다.

• Journal of Dental Anesthesia and Pain Medicine
• /
• 제21권5호
• /
• pp.413-429
• /
• 2021

Background: Migraine headaches are the second leading cause of disability worldwide and are responsible for significant morbidity, reduction in the quality of life, and loss of productivity on a global scale. The purpose of this systematic review and meta-analysis was to evaluate the efficacy of ketamine on migraines and other primary headache disorders compared to placebo and other active interventions, such as midazolam, metoclopramide/diphenhydramine, and prochlorperazine/diphenhydramine. Methods: An electronic search of databases published up to February 2021, including Medline via PubMed, EMBASE, Web of Science, and Cochrane Library, a hand search of the bibliographies of the included studies, as well as literature and systematic reviews found through the search was conducted to identify randomized controlled trials (RCTs) investigating ketamine in the treatment of migraine/headache disorders compared to the placebo. The authors assessed the risk of bias according to the Cochrane Handbook guidelines. Results: The initial search strategy yielded 398 unduplicated references, which were independently assessed by three review authors. After evaluation, this number was reduced to five RCTs (two unclear risk of bias and three high risk of bias). The total number of patients in all the studies was 193. Due to the high risk of bias, small sample size, heterogeneity of the outcomes reported, and heterogeneity of the comparison groups, the quality of the evidence was very low. One RCT reported that intranasal ketamine was superior to intranasal midazolam in improving the aura attack severity, but not duration, while another reported that intranasal ketamine was not superior to metoclopramide and diphenhydramine in reducing the headache severity. In one trial, subcutaneous ketamine was superior to saline in migraine severity reduction; however, intravenous (I.V.) ketamine was inferior to I.V. prochlorperazine and diphenhydramine in another study. Conclusion: Further double-blind controlled studies are needed to assess the efficacy of ketamine in treating acute and chronic refractory migraines and other primary headaches using intranasal and subcutaneous routes. These studies should include a long-term follow-up and different ketamine dosages in diagnosed patients following international standards for diagnosing headache/migraine.

• Animal Bioscience
• /
• 제35권3호
• /
• pp.422-433
• /
• 2022

Objective: Two follow-up studies (exp. 1 and 2) were conducted to determine the effects of L-glutamine (L-Gln) supplementation on degradation and rumen fermentation characteristics in vitro. Methods: First, rumen liquor from three cannulated cows was used to test L-Gln (50 mM) degradation rate and ammonia-N production at 6, 12, 24, 36, and 48 h after incubation (exp. 1). Second, rumen liquor from two cannulated steers was used to assess the effects of five levels of L-Gln including 0% (control), 0.5%, 1%, 2%, and 3% at 0, 3, 6, 12, 24, 36, and 48 h after incubation on fermentation characteristics, gas production, and degradability of nutrients (exp. 2). Results: In exp. 1, L-Gln degradation rate and ammonia-N concentrations increased over time (p<0.001). In exp. 2, pH was reduced significantly as incubation time elapsed (p<0.001). Total gas production tended to increase in all groups as incubation time increased. Acetate and propionate tended to increase by increasing glutamine (Gln) levels, whereas levels of total volatile fatty acids (VFAs) were the highest in 0.5% and 3% Gln groups (p<0.001). The branched-chain VFA showed both linear and quadratic effects showing the lowest values in the 1% Gln group particularly after 6 h incubation (p<0.001). L-Gln increased crude protein degradability (p<0.001), showing the highest degradability in the 0.5% Gln group regardless of incubation time (p<0.05). Degradability of acid detergent fiber and neutral detergent fiber showed a similar pattern showing the highest values in 0.5% Gln group (p<0.10). Conclusion: Although L-Gln showed no toxicity when it was supplemented at high dosages (2% to 3% of DM), 0.5% L-Gln demonstrated the positive effects on main factors including VFAs production in-vitro. The results of this study need to be verified in further in-vivo study.

• 한국작물학회지
• /
• 제35권3호
• /
• pp.218-223
• /
• 1990

벼 기계이항답에서 후기의 도복을 경감시켜 농작업의 효율성을 높이고 수량손실을 방지하기 위하여 개발중인 도복경감제 'KIM-112'의 효과를 검토하고자 처리시기 및 약량을 달리하여 수행한 시험결과를 요약하면 다음과 같다. 1. KIM-112의 출수전 30일-5일 처리는 간장을 크게 단축시켰는데 10a당 1g 처리에서는 처리시기에 따라 10-17%, 2g 처리에서는 16-23%의 간장단축효과가 있었다. 2. 절간장 단축정도는 처리시기에 따라 다르게 나타났는데 출수전 30일 처리에서는 5절간이 약 50%정도 단축되었으며 처리시기가 늦어질수록 상위절간의 단축이 커지는 경향이었고, 약량별로는 2g 처리가 다소 높았다. 3. 간장과 도복지수와는 간장이 길어질수록 도복지수가 높아지는 정의 관계가 있었으며, 특히 1절간장과 4절간장이 도복지수에 크게 영향을 미쳤다. 4. KIM-112는 간벽 간경 간기중 등의 도복형질에는 영향을 미치지 않았고, 좌절중의 증대와 간장단축에 따른 moment의 감소로 내도복성을 향상시켰으며, 도복지수는 좌절중 moment 이삭중과 높은 상관이 있었다. 5. 약제처리시기와 약량에 따라 출수가 1-4일 지연되었으며, 수장이 짧아짐에 따라 수당립수가 다소 적었으나 도복이 되지 않아 등숙율의 향상으로 수량은 약간 증수되었다.

• 한국건축시공학회지
• /
• 제23권6호
• /
• pp.703-714
• /
• 2023

본 연구에서는 효율적인 콘크리트용 당류계 초지연제를 개발하기 위해 현재 시판되고 있는 당 성분의 물질들을 대상으로 이들의 종류 및 혼입률 변화에 따른 시멘트 페이스트의 응결지연 특성, 압축강도 발현 특성 및 미시구조 특성을 분석하고자 하였다. 당류계 초지연성 혼화제 중 백설탕, 슈가파우더 및 스테비오사이드를 사용할 경우 응결지연에 효율적인 것으로 나타났다. 슈가파우더 및 스테비오사이드를 제외한 여타 배합의 경우 Plain 대비 동등한 수준의 압축강도를 발휘하는 것으로 나타났다. 특히, 백설탕의 경우 0.2% 혼입시 재령 1일에서 강도가 발휘되지 않다가 재령 28일에서는 Plain과 비교하여 동등 이상의 강도를 발휘하는 것으로 나타났다. XRD, SEM 및 EDS 분석 결과, XRD를 통해 백설탕에 의한 C₃S의 수화지연(응결 지연)을 확인하였으며, EDS의 정량 분석을 통해 추가적으로 확인할 수 있었다. 수화물의 유무는 SEM를 이용하여 존재를 확인하였다. 본 연구 범위에 한하여 콘크리트용 당류계 초지연성 혼화제로써 백설탕을 사용할 경우 응결지연 성능 및 압축강도 발현 성능에 효과적일 것으로 판단된다.

• 한국가축번식학회지
• /
• 제24권3호
• /
• pp.241-248
• /
• 2000

본 연구는 생약제재가 dioxin의 연속투여시 생식독성 완화에 미치는 영향을 구명하고저 30 $\mu\textrm{g}$/kg의 dioxin을 5일간 연속투여 후 생약제재를 3주간격일로 경구투여 했을 때 정자수, 정자활력, 정소중량 및 정소조직에 미치는 영향을 조사하였다. 1. Dioxin 10~20 $\mu\textrm{g}$/kg을 5일간 연속투여한 군의 정자수는 90.7$\pm$3.6~l18.5$\pm$3.6$\times$$10^{6}$$m\ell$, 30~40 $\mu\textrm{g}$/kg투여군의 정자수는 67.3$\pm$4.1~88.2$\pm$3.3$\times$$10^{6}$$m\ell$로서 대조군의 119.3$\pm$3.4~120.2$\pm$4.7$\times$$10^{6}$$m\ell$에 비해 현저히 감소된 정자수를 나타냈다(p<0.05). 2. dioxin 10~20 $\mu\textrm{g}$/kg 투여군의 정자활력은 77.0$\pm$4.7~89.5$\pm$3.6%, 30~40$\mu\textrm{g}$/kg 투여군은 66.5$\pm$3.3~79.9$\pm$3.8%로서 대조군의 93.6$\pm$3.8~94.9$\pm$3.4%에 비해 현저히 감소된 정자활력을 나타냈다(p<0.05). 3. Dioxin 30 $\mu\textrm{g}$/kg을 5일간 연속투여 후 녹차, 홍삼, 구기자, 오메 추출물을 격일로 3주간 투여했을 때 정자수는 각각 77.4$\pm$3.2~90.9$\pm$3.4$\times$$10^{6}$$m\ell$, 78.0$\pm$3.3~105.0$\pm$4.2$\times$$10^{6}$$m\ell$, 76.2$\pm$2.8 ~84.4$\pm$3.5$\times$$10^{6}$$m\ell$, 75.4$\pm$3.3~80.2$\pm$3.3$\times$$10^{6}$$m\ell$이었다. 4. Dioxin 30 $\mu\textrm{g}$/kg을 5일간 연속투여 후 녹차, 홍삼, 구기자, 오메 추출물을 격일로 3주간 투여했을 때 정자활력은 대조군의 119.3$\pm$3.4~120.2$\pm$4.7$\times$$10^{6}$$m\ell$와 93.0$\pm$3.5~96.1$\pm$3.5%에 비해 홍삼추출물 투여군에서는 회복이 현저하였고(p<0.05), 녹차는 다음이었으며, 구기자, 오메는 회복이 미미하였다. 5. Dioxin 30 $\mu\textrm{g}$/kg을 5일간 연속투여 후 녹차, 홍삼, 구기자, 오메 추출물을 각각 격일로 3주간 투석했을 때 정소중량은 대조군의 0.15$\pm$0.01~0.16$\pm$0.01g에 비해 낮은 치를 나타냈으며 홍삼추출물 투여군에서는 회복효과가 현저하였다. 6. Dioxin 30 $\mu\textrm{g}$/kg을 5일간 연속투여 후 녹차, 홍삼, 구기자, 오메를 각각 3주간 격일로 경구 투여했을 때 간, 비장 및 정소조직은 대조군에 비해 심한 손상이 관찰되었으며, 정소는 홍삼 투여군에서 많은 회복이 관찰되었다.

• 생명과학회지
• /
• 제25권8호
• /
• pp.889-895
• /
• 2015

혈관내피세포 기능장애는 동맥경화증 발생의 초기단계이다. 비타민B군(B6, B12, 엽산)은 혈관항상성에 중요한 인자이다. 이들 비타민B군이 결핍되면 혈관항상성에 변화가 생겨 심혈관질환을 유발한다. 비타민B군 중 엽산은 내피세포에서 산화질소 항상성에 중요한 역할을 한다. 동맥경화증에 관련된 섭취엽산의 용량의존적 효과를 알기 위해, C57BL/6 쥐의 대동맥이완과 간 C반응단백질 수준을 연구하였다. 본 연구는 총 54마리의 C57BL/6 쥐를 서양식이군과 대조식이군으로 나누고, 각각은 다시 엽산섭취용량(0.2, 2, 8mg/kg)에 따라 3형태의 하위집단으로 나누었다. 18개월 동안의 식이섭취후, 양군의 8mg/kg 엽산섭취용량에서는 대동맥 이완반응을 전혀 나타내지 않았고 양군의 차이도 없었다(p<0.05). 모든 엽산섭취용량(0.2, 2, 8mg/kg)에서 간 C반응단백질 수준은 대조식이군보다 서양식이군에서 더 높았다(p=0.035). 양군의 간 C반응단백질 수준은 0.2 mg/kg 엽산섭취용량에서 가장 낮았다(p<0.05). 결론적으로, C57BL/6 쥐에서 식이에 관계없이 0.2 mg/kg 엽산섭취용량만으로도 대동맥의 이완반응을 유도하고 간 C반응단백질 수준을 낮춤으로써 동맥경화증을 충분히 예방할 수 있다.